Intelligent Bio Solutions (INBS) EBITDA (2019 - 2025)

Intelligent Bio Solutions' EBITDA history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2025.

• In Q1 2025, EBITDA rose 22.23% year-over-year to -$2.4 million; the TTM figure through Mar 2025 stood at -$10.1 million (changed 0.42% YoY), while the FY2024 annual figure was -$10.3 million, up 1.76% from the prior year.
• EBITDA was -$2.4 million for Q1 2025 at Intelligent Bio Solutions, down from -$2.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$59003.0 in Q4 2022 to a low of -$6.4 million in Q1 2023.
• Historically, EBITDA has averaged -$2.4 million across 5 years, with a median of -$2.4 million in 2025.
• The sharpest annual moves came in 2021 and 2022: EBITDA slumped 11712.03% in 2021, then soared 98.29% in 2022.
• A 5-year view of EBITDA shows it stood at -$3.5 million in 2021, then jumped by 98.29% to -$59003.0 in 2022, then sank by 3122.29% to -$1.9 million in 2023, then decreased by 26.23% to -$2.4 million in 2024, then decreased by 1.45% to -$2.4 million in 2025.
• The last three EBITDA figures came in at -$2.4 million (Q1 2025), -$2.4 million (Q4 2024), and -$2.5 million (Q3 2024), per Business Quant data.